前锯肌平面阻滞对老年病人胸腔镜下外科房颤消融术后炎症因子的影响

doi:10.3969/j.issn.1003-9198.2024.12.012

摘要/Abstract

摘要： 目的评估超声引导下前锯肌平面阻滞(SAPB)联合全身麻醉对行胸腔镜下外科房颤消融术老年病人炎症因子水平的影响。方法本研究为单中心、前瞻性、随机对照试验,共纳入80例老年病人,随机分配至SAPB组和对照组,SAPB组术前行超声引导下双侧SAPB(0.375%罗哌卡因20 mL),对照组术前不行阻滞,比较2组术后24 h内炎症因子水平的变化。结果与对照组相比,SAPB组的IL-6和hs-CRP水平显著下降(P＜0.01)。此外,SAPB组病人术后部分生命体征指标更加稳定,疼痛评分显著低于对照组(P＜0.01)。结论 SAPB联合全身麻醉能够有效降低胸腔镜下外科房颤消融术病人术后炎症反应,有利于术后恢复。

关键词: 神经阻滞, 房颤, 炎症因子, 老年人, 手术消融

Abstract: Objective To evaluate the effect of ultrasound-guided serratus anterior plane block (SAPB) combined with general anesthesia on postoperative inflammatory factors in the elderly patients undergoing thoracoscopic surgical ablation for atrial fibrillation. Methods This study was a single-center, prospective, randomized controlled trial involving 80 elderly patients, who were randomly divided into SAPB group and control group. The SAPB group received preoperative ultrasound-guided bilateral SAPB (20 mL of 0.375% ropivacaine on each side), while the control group did not receive nerve block. The levels of the inflammatory factors within 24 hours after the operation were compared between the two groups. Results The levels of interleukin-6 (IL-6) and high sensitivity C-reaction protein (hs-CRP) in the SAPB group were significantly lower than those in the control group (P＜0.01). The SAPB group showed more stable postoperative vital signs and significantly lower pain scores compared to the control group (P＜0.01). Conclusions SAPB combined with general anesthesia can effectively reduce postoperative inflammation in the elderly patients undergoing thoracoscopic surgical ablation for atrial fibrillation, and improve the postoperative recovery.

Key words: nerve block, atrial fibrillation, inflammatory factor, aged, surgical ablation

中图分类号:

R 614.4

许佩龙, 王敏, 陈宇, 陈晓东. 前锯肌平面阻滞对老年病人胸腔镜下外科房颤消融术后炎症因子的影响[J]. 实用老年医学, 2024, 38(12): 1242-1245.

XU Peilong, WANG Min, CHEN Yu, CHEN Xiaodong. Effect of serratus anterior plane block on inflammatory factors in elderly patients undergoing thoracoscopic surgical ablation for atrial fibrillation[J]. Practical Geriatrics, 2024, 38(12): 1242-1245.

参考文献

[1] KORNEJ J, BORSCHEL C S, BENJAMIN E J, et al. Epidemiology of atrial fibrillation in the 21st Century[J]. Circ Res, 2020, 127(1): 4-20.
[2] 薛芝, 齐国祥, 高行娟,等. 非瓣膜性心房颤动患者抗凝治疗现状与影响因素分析[J]. 临床药物治疗杂志, 2023, 21(7):39-45.
[3] KAMIOKA M, YOSHIHISA A, HIJIOKA N, et al. The efficacy of combination of transcatheter atrial septal defects closure and radiofrequency catheter ablation for the prevention of atrial fibrillation recurrence through bi-atrial reverse remodeling[J]. J Interv Card Electrophysiol, 2020, 59(2):365-372.
[4] 彭文星, 张芸楠, 林阳. 急性冠脉综合征合并心房颤动患者抗栓治疗方案分析[J]. 临床药物治疗杂志, 2022, 20(6):29-35.
[5] CUSACK B,BUGGY D J. Anaesthesia, analgesia, and the surgical stress response[J]. BJA Educ, 2020, 20(9): 321-328.
[6] LOPES L A, AGRAWAL D K. Post-operative atrial fibrillation: current treatments and etiologies for a persistent surgical complication[J]. J Surg Res: Houst, 2022, 5(1): 159-172.
[7] NOMANI H, MOHAMMADPOUR A H, MOALLEM S M H, et al.Anti-inflammatory drugs in the prevention of post-operative atrial fibrillation: a literature review[J]. Inflammopharmacology, 2020, 28(1):111-129.
[8] SEMYONOV M, FEDORINA E, SHALMAN A, et al. Serratus anterior block for long-term post-thoracoscopy pain management[J]. J Pain Res, 2021, 14:3849-3854.
[9] PEREZ-HERRERO M A, FAJARDO PEREZ M, YAMAK ALTINPULLUK E, et al. Usefulness of ultrasound-guided serratus-anterior block in prevention of postoperative pain after breast surgery. A cohort study[J]. J Clin Anesth,2024,93:111360.
[10] EOCHAGAIN A N, CAROLAN S, BUGGY D J. Regional anaesthesia truncal blocks for acute postoperative pain and recovery: a narrative review[J]. Br J Anaesth, 2024, 132(5):1133-1145 .
[11] RENGEL K F, PANDHARIPANDE P P, HUGHES C G. Postoperative delirium[J]. Presse Med, 2018,47(4 Pt 2):e53-e64.
[12] ABUBAKAR M, RASOOL H F, JAVED I, et al. Comparative roles of IL-1, IL-6, IL-10, IL-17, IL-18, 1L-22, IL-33, and IL-37 in various cardiovascular diseases with potential insights for targeted immunotherapy[J]. Cureus, 2023,15(7):e42494.
[13] ALI S B, CECCHIN A, LUCCHESI C, et al. Can C-reactive protein be used as a surrogate marker of IL-6 in a broad array of clinical entities?[J]. Biomark Med, 2023, 17(24):1001-1010.
[14] LI X, WU X, CHEN X, et al. Selective blockade of interleukin 6 trans-signaling depresses atrial fibrillation[J]. Heart Rhythm, 2023, 20(12):1759-1770.
[15] LOTFI M E, PEZESHKI P S, REZAEI N. The role of interleukins in pathogenesis and prognosis of atrial fibrillation[J]. Expert Rev Clin Immunol, 2023, 19(6):585-597.
[16] GUO X, MA L. Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol–related inflammatory parameters as predictors[J]. Coron Artery Dis, 2023, 34(1):66-77.
[17] GAO Y, WANG M, WANG R, et al. The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study[J]. Lipids Health Dis, 2024, 23(1):66.
[18] MUDULI S, GUPTA M D, GIRISH M, et al. Anti-inflammatory therapy in atherosclerotic cardiovascular disease: Current reappraisal[J]. Indian Heart J, 2023, 75(6):391-397.
[19] FARSHIDIANFAR M, ARDEKANI A, TABRIZI R, et al. Effects of melatonin on cardiac injury and inflammatory biomarkers in patients undergoing coronary artery bypass graft surgery: a meta-analysis[J]. Cardiol Ther, 2023,12(1):11-20.
[20] HEO R H, WANG M K, MEYRE P B, et al. Associations of inflammatory biomarkers with the risk of morbidity and mortality after cardiac surgery: a systematic review and meta-analysis[J]. Can J Cardiol, 2023, 39(11):1686-1694.